Takeda Pharmaceutica (TKPHF) 50.5000 $TKPHF Orexigen

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Takeda Pharmaceutica (TKPHF) 50.5000 $TKPHF

Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker
Brian Orelli, The Motley Fool - Motley Fool - Sat May 16, 10:04AM CDT
Orexigen Therapeutics has been the darling of the obesity drugmakers, doing something Arena Pharmaceuticals and VIVUS weren't able to do: keep its share price above where it was when its weight-loss drug was approved in September. ...
OREX: 4.98 (-0.03), VVUS: 2.56 (+0.05), ARNA: 4.39 (+0.14)

Seeking Alpha's Biotech Weekly: Orexigen's Wreck, Stagnant Gilead, And More
SA Editor Mike Taylor - Seeking Alpha - Fri May 15, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors weighed the options for Orexigen (NASDAQ: OREX ) after the...
PRGO: 198.37 (+3.87), VRTX: 127.31 (+1.10), OVAS: 30.01 (+0.84), MYL: 71.38 (+0.71), AMGN: 163.44 (+1.08), GSK: 44.66 (-0.11), ALR: 50.79 (+0.04), ONTY: 2.59 (+0.16), CELG: 116.37 (+0.84), PVCT: 0.85 (-0.02), JNJ: 103.42 (+1.12), OREX: 4.98 (-0.03), FCSC: 3.92 (-0.10), NVIV: 12.09 (-0.97), GILD: 111.00 (+1.70), GWPH: 112.93 (+0.68), CTSO: 6.24 (+0.31), ACHN: 11.03 (+1.46), RMD: 56.81 (+0.61), SNY: 50.40 (-0.12), PBYI: 181.30 (+4.29)

Dendrimers Coming Of Age: Starpharma's Star Is Rising
Keith Williams - at Seeking Alpha - Fri May 15, 11:05AM CDT

PFE: 33.98 (-0.01), AZN: 68.74 (-0.55), LLY: 72.94 (+0.04), SNY: 50.40 (-0.12)

How Not To Handle Your Clinical Data
Derek Lowe - Seeking Alpha - Wed May 13, 11:59AM CDT
We turn now to Orexigen (NASDAQ: OREX ), one of the small companies trying to make headway in the obesity market. Earlier this year, a patent application from them published, claiming that their drug ( Contrave , a sustained release formulation...
OREX: 4.98 (-0.03)

Takeda - Orexigen partnership on the rocks after CV outcomes study halted
Seeking Alpha - at Seeking Alpha - Wed May 13, 6:25AM CDT

OREX: 4.98 (-0.03)

First patient dosed in Takeda's Phase 3 study of proteasome inhibitor in myeloma
Seeking Alpha - at Seeking Alpha - Tue May 12, 6:31AM CDT


Infinity Pharmaceuticals: Analyzing The Impact Of Repurchasing Takeda's Royalty Agreement
Jonathan Liu - at Seeking Alpha - Mon Apr 13, 7:50PM CDT

INFI: 12.92 (+0.62), ABBV: 65.61 (-0.38)

Takeda Pharma offers $2.2B to settle Actos cases
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 6:31AM CDT

LLY: 72.94 (+0.04)

Infinity Pharma buys out royalty obligations from Takeda for $52.5M
Seeking Alpha - at Seeking Alpha - Tue Mar 31, 10:30AM CDT

ABBV: 65.61 (-0.38), INFI: 12.92 (+0.62)

Why ImmunoGen Inc. is Soaring Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Mon Mar 23, 2:25PM CDT
Although we don't believe in   timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. ImmunoGen, What's happening: Shares in ...
IMGN: 8.67 (+0.08), AMGN: 163.44 (+1.08), LLY: 72.94 (+0.04)

Takeda licenses ImmunoGen's ADC technology to develop cancer therapeutics
Seeking Alpha - at Seeking Alpha - Mon Mar 23, 6:47AM CDT

IMGN: 8.67 (+0.08)

Orexigen torpedoes shorts on news of Contrave's heart safety benefit
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 12:03PM CST

OREX: 4.98 (-0.03), VVUS: 2.56 (+0.05), ARNA: 4.39 (+0.14)

Amgen's Kyprolis beats Takeda's Velcade in head-to-head study
Seeking Alpha - at Seeking Alpha - Sun Mar 01, 10:53PM CST

AMGN: 163.44 (+1.08)

Heptares Takes Sosei Out Of Its Comfort Zone
EP Vantage - Seeking Alpha - Mon Feb 23, 2:37PM CST
It makes perfect sense for a small Japanese company to harbour expansion plans, but the private UK neuroscience player Heptares Therapeutics makes an unusual bedfellow for Sosei ( OTC:SOLTF ) , a group with a predominantly respiratory focus....
AZN: 68.74 (-0.55), NVS: 104.06 (+0.31)

Interim results positive for Takeda blood cancer med
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 6:17AM CST


Canada accepts Sucampo's NDS for constipation med
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 6:38AM CST

SCMP: 16.04 (+0.10)

AMAG and Takeda part ways on ferumoxytol
Seeking Alpha - at Seeking Alpha - Mon Dec 29, 7:31AM CST

AMAG: 65.33 (+3.36)

Seattle Genetics down on ASH presentations
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 11:37AM CST

SGEN: 40.50 (+0.56), AZN: 68.74 (-0.55), MRK: 60.01 (-0.22), BMY: 68.00 (+0.36), CELG: 116.37 (+0.84), FPRX: 21.32 (+0.21)

Takeda's ixazomib a Breakthrough Therapy for amyloidosis
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 9:26AM CST


GE Healthcare and Takeda team up in liver disease R&D
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:22AM CST


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading